These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32960007)

  • 21. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
    J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
    Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial.
    Arun JJ; Lodha R; Kabra SK
    BMC Pediatr; 2012 Mar; 12():21. PubMed ID: 22394648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Eosinophil Cationic Protein Is a Useful Marker for Assessing the Efficacy of Inhaled Corticosteroid Therapy in Children with Bronchial Asthma.
    Guo CL; Sun XM; Wang XW; Guo Q
    Tohoku J Exp Med; 2017 Aug; 242(4):263-271. PubMed ID: 28781336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs.
    Turner DL; Ferrari N; Ford WR; Kidd EJ; Paquet L; Renzi P; Broadley KJ
    Eur J Pharmacol; 2010 Sep; 641(2-3):213-9. PubMed ID: 20639142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study].
    Chen ZG; Li M; Chen H; Chen YF; Chen FH; Ji JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):470-2. PubMed ID: 18359717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nebulized budesonide to treat acute asthma in children].
    Milani GK; Rosário Filho NA; Riedi CA; Figueiredo BC
    J Pediatr (Rio J); 2004; 80(2):106-12. PubMed ID: 15079179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium.
    Persdotter S; Lindahl M; Malm-Erjefalt M; von Wachenfeldt K; Korn SH; Stevens T; Miller-Larsson A
    Int Arch Allergy Immunol; 2007; 143(3):201-10. PubMed ID: 17290146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
    Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
    Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma.
    Devidayal ; Singhi S; Kumar L; Jayshree M
    Acta Paediatr; 1999 Aug; 88(8):835-40. PubMed ID: 10503681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of conditioned immune response in curing bronchial asthma in mice].
    Li HB; Han XZ; Feng YZ; Wang JR; Sun Y; Sun LF; Yi YC; Li ZP
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):924-9. PubMed ID: 19134256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of eosinophil transepithelial migration and downregulation of adhesion molecule expression on eosinophils and airway epithelial cells induced by budesonide.
    Gonzalez Rodriguez R; Silvestri M; Cordone A; Salami A; Rossi GA
    Pulm Pharmacol Ther; 2000; 13(1):31-8. PubMed ID: 10718988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of andrographolide on the expression of eosinophil granulocytes and possible mechanisms].
    Li YH; Wang MY; Jin R; Guo S; Fan XY; Ma H; Wu LX; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):371-4. PubMed ID: 22613110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
    Vatrella A; Ponticiello A; Parrella R; Romano L; Zofra S; DiLeva A; Bariffi F
    Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
    Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
    Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percentage of eosinophils with surface CD44 and levels of eosinophil cationic protein in the peripheral blood in children with bronchial asthma and their changes after montelukast therapy.
    Kopriva F; Szotkowská J; Ordeltová M; Zápalka M
    Allergy Asthma Proc; 2006; 27(4):378-82. PubMed ID: 16948353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.